Target Information

Recently acquired by Efor, Project Delivery Partners (PDP) is a Singapore-based company that has been active for 10 years in the fields of commissioning, qualification, and validation (CQV), engineering, and the management of complex projects. With a workforce of over 250 employees, PDP has established a strong presence in Southeast Asia, Europe, and North America. This acquisition significantly bolsters Efor's international footprint and strengthens its historical market positions.

Industry Overview in Singapore

Singapore has become a vital hub for life sciences, driven by substantial government investment, a robust regulatory framework, and a highly skilled workforce. The country is recognized for its research and development capabilities, attracting global pharmaceutical and biotechnology companies that seek to leverage its strategic location within Asia. Furthermore, Singapore's commitment to innovation and the advancement of healthcare technologies has positioned it as a key player in the global life sciences market.

In recent years, the local industry has experienced significant growth fueled by the increasing demand for healthcare solutions, particularly in response to an aging population and the rising prevalence of chronic diseases. This trend has led to the establishment of numerous research institutions, partnerships, and collaborations, enhancing Singapore's reputation as a center of excellence in life sciences.

Additionally, the local government has implemented initiatives to promote public-private partnerships and support start-ups specializing in biopharmaceuticals and medical technology. This collaborative environment fosters innovation and attracts investment, further solidifying Singapore's status in the Asia-Pacific region as an industry leader.

As a result, companies operating in Singapore's life sciences sector can benefit from a dynamic ecosystem that encourages growth and sustainability. Efor's expansion into this market through the acquisition of PDP illustrates its commitment to leverage opportunities in this flourishing industry.

Rationale Behind the Deal

The acquisition of Project Delivery Partners is a strategic move for Efor to enhance its ambition of becoming a global leader in the life sciences consulting space. By integrating PDP, Efor consolidates its presence in key markets such as Singapore, the United States, Canada, Ireland, and Switzerland, allowing for greater synergy and collaboration across geographies.

This strategic acquisition aligns with Efor's vision to drive organic growth and pursue targeted acquisitions, bolstering the company's capabilities to meet the complex needs of its global clientele. The anticipated revenue growth to 600 million euros by 2028 demonstrates Efor's commitment to achieving ambitious goals through this integration.

Investor Information

Efor, a leading French consulting group in life sciences, has rapidly expanded its reach and expertise in the industry. The company's success is largely attributed to its strategic acquisitions and strong focus on providing tailored solutions to clients. Efor's commitment to excellence, engagement, and collaboration has driven its impressive growth trajectory.

The acquisition of PDP is supported by a robust consortium, which includes RAISE Invest and its philanthropic fund

View Original Article